Çocukluk Çağı Romatizmal Hastalıklarında Kardiyovasküler Sistem Tutulumu

Doria A, Iaccarino L, Sarzi-Puttini P et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14:683– 686.
Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation 2010;121(4):586–613.
Schwartz T, Diederichsen LP, Lundberg IE et al. Cardiac involvement in adult and juvenile idiopathic infammatory myopathies. RMD Open 2016;2:e00029.
Groot N, Shaikhani D, Teng YKO, et al. Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus. Arthritis Rheumatol 2019;71(2):290–301.
Sozeri B, Deveci M, Dincel N, et al. The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol 2013;28(3): 471–6.
Civieri G, Castaldi B, Martini G et al. Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography. Rheumatology (Oxford) 2021;60:103–107.
Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile Idiopathic Arthritis. Balkan Med J. 2017 Apr 5;34(2):90-101.
Shen C-C, Yao T-C, Yeh K-W, et al. Association of disease activity and antirheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: a prospective study. Semin Arthritis Rheum 2013;42(6):590–6.
Koca B, Sahin S, Adrovic A, Barut K, Kasapcopur O. Cardiac involvement in juvenile idiopathic arthritis. Rheumatol Int. 2017 Jan;37(1):137-142.
Gedalia A, Giannini EH, Brewer EJ, Person DA. Prevalence of pericardial effusion by echocardiography in juvenile rheumatoid arthritis. J Rheumatol. 1993 Jan;20(1):206-7.
Arsenaki E, Georgakopoulos P, Mitropoulou P, Koutli E, Thomas K, Charakida M, Georgiopoulos G. Cardiovascular Disease in Juvenile Idiopathic Arthritis. Curr Vasc Pharmacol. 2020;18(6):580-591.
Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020 Feb;16(1):19-30
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. 2023 Oct;42(10):2703-2715.
Chang JC, Xiao R, Mercer-Rosa L et al (2018) Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adultonset disease. Lupus 27:2146–2154. https://doi.org/10.1177/ 0961203318804889, Harrison MJ, Zühlke LJ, Lewandowski LB, Scott C (2019) Pediatric systemic lupus erythematosus patients in South Africa have high prevalence and severity of cardiac and vascular manifestations. Pediatr Rheumatol 17:76. https://doi.org/ 10.1186/s12969-019-0382-
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. 2023 Oct;42(10):2703-2715.
Zen, M., Salmaso, L., Amidei, C. B., Fedeli, U., Bellio, S., Iaccarino, L., ... & Saia, M. (2023). Mortality and causes of death in systemic lupus erythematosus over the last decade: data from a large population-based study. European Journal of Internal Medicine, 112, 45-51.
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. 2023 Oct;42(10):2703-2715.
Jaeggi ET, Hamilton RM, Silverman ED et al (2002) Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. J Am Coll Cardiol 39:130–137.
Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al. Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus. Circulation 2012; 126:76– 82.
Paik JJ, Lubin G, Gromatzky A, Mudd PN Jr, Ponda MP, Christopher-Stine L. Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review. Clin Exp Rheumatol. 2023 Mar;41(2):348-358.
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. 2023 Oct;42(10):2703-2715.
Rutkowska-Sak L, Gietka P, Gazda A, Kołodziejczyk B. Juvenile systemic sclerosis - observations of one clinical centre. Reumatologia. 2021;59(6):367-372.
Foeldvari I, Klotsche J, Torok KS et al (2019) Are difuse and limited juvenile systemic sclerosis diferent in clinical presen tation? Clinical characteristics of a juvenile systemic sclerosis cohort. J Scleroderma Relat Disord 4:49–61.
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. 2023 Oct;42(10):2703-2715.
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. 2023 Oct;42(10):2703-2715.
Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 2012;7:e38998.
Kato K, Sullivan PF, Evengård B, Pedersen NL (2006) Chronic Widespread Pain and Its Comorbidities: A Population-Based Study. Arch Intern Med 166:1649–1654.
[Oates-Whitehead RM, Baumer JH, Haines L, et al (2003) Intra venous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2021. https://doi.org/ 10.1002/14651858.CD004000].
Batu ED, Ozen S. Pediatric vasculitis. Curr Rheumatol Rep. 2012 Apr;14(2):121-9.
Vats, V., Patel, K., Sharma, D. D., Almansouri, N. E., Makkapati, N. S. R., Nimal, S., ... & Raut, Y. (2023). Exploring Cardiovascular Manifestations in Vasculitides: An In-Depth Review. Cureus, 15(8).
Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., ... & Taubert, K. A. (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 110(17), 2747-2771.
Mathew AJ, Goel R, Kumar S, Danda D. Childhood-onset Takayasu arteritis: an update. Int J Rheum Dis. 2016 Feb;19(2):116-26.
Kerr GS, Hallahan CW, Giordano J et al.Takayasu Arteri tis. Ann Intern Med 1994; 120:919–929.
Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol 1998;66:S85–S90.
Danda D, Goel R, Joseph G et al (2021) Clinical course of 602 patients with Takayasu’s arteritis: comparison between Child hood-onset versus adult onset disease. Rheumatology (Oxford) 60:2246–2255.
Vats V, Patel K, Sharma DD, Almansouri NE, Makkapati NSR, Nimal S et al. (2023). Exploring Cardiovascular Manifestations in Vasculitides: An In-Depth Review. Cureus, 15(8).
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al.2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitisdes. Arthritis Rheum 2013; 65:1-11
Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group database. Arthritis Rheum 2010;62:616–26
Ozen S, Besbas N, Saatci U, Bakkaloglu A (1992) Diagnostic cri teria for polyarteritis nodosa in childhood. J Pediatr 120:206–209.
Eirín, E. M., Ouréns, Y. S., & Vázquez, J. L. G. (2021). Cardiac manifestations of rheumatic diseases. Medicina Clínica (English Edition), 156(12), 615-621